Amanote Research
Register
Sign In
Orphan Designation: Recombinant Human Club Cell 10 KDa Protein, Treatment of Bronchiolitis Obliterans Syndrome
Case Medical Research
doi 10.31525/cmr-f62e6a
Full Text
Open PDF
Abstract
Available in
full text
Date
April 8, 2019
Authors
Unknown
Publisher
Case Journals
Related search
Orphan Designation: Recombinant Human Hepatocarcinoma-Intestine-Pancreas,pancreatic Associated Protein, Treatment of Acute Liver Failure
Case Medical Research
Orphan Designation: Dantrolene Sodium, Treatment of Wolfram Syndrome
Case Medical Research
Club Cell 10-kDa Protein Attenuates Airway Mucus Hypersecretion and Inflammation
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Orphan Designation: Recombinant Human Anti-Interferon Gamma Monoclonal Antibody (Emapalumab), Treatment of Haemophagocytic Lymphohistiocytosis
Case Medical Research
Orphan Designation: Mogamulizumab, Treatment of Cutaneous T-Cell Lymphoma
Case Medical Research
Orphan Designation: Brincidofovir, Treatment of Smallpox
Case Medical Research
Developing a Novel Inhaled Therapeutic for the Treatment of Bronchiolitis Obliterans Syndrome
Orphan Designation: 3-Pentylbenzeneacetic Acid Sodium Salt, Treatment of Alström Syndrome
Case Medical Research
Lung Function Trajectory in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplant
Annals of the American Thoracic Society
Pulmonary
Respiratory Medicine
